NAA20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.128800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.081600E-01
Normal-vs-Stage2
7.080400E-01
Normal-vs-Stage3
9.729400E-01
Normal-vs-Stage4
9.605000E-01
Stage1-vs-Stage2
2.076200E-01
Stage1-vs-Stage3
2.418000E-01
Stage1-vs-Stage4
2.464600E-01
Stage2-vs-Stage3
6.300600E-01
Stage2-vs-Stage4
7.130800E-01
Stage3-vs-Stage4
9.373400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.968000E-01
Normal-vs-AfricanAmerican
5.875600E-01
Normal-vs-Asian
9.946800E-01
Caucasian-vs-AfricanAmerican
8.858300E-02
Caucasian-vs-Asian
2.348000E-02
AfricanAmerican-vs-Asian
5.071800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.583000E-01
Normal-vs-Female
5.778400E-01
Male-vs-Female
4.869800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.349200E-01
Normal-vs-Age(41-60Yrs)
9.624400E-02
Normal-vs-Age(61-80Yrs)
7.742600E-01
Normal-vs-Age(81-100Yrs)
5.468600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.587000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.088000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.759000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.815200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.079230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.162800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.001400E-01
Normal-vs-Daily Drinker
5.608000E-01
Normal-vs-Weekly Drinker
6.420600E-01
Normal-vs-Occasional Drinker
2.053200E-01
Normal-vs-Social Drinker
6.493200E-01
Non Drinker-vs-Daily Drinker
1.674990E-01
Non Drinker-vs-Weekly Drinker
3.647200E-01
Non Drinker-vs-Occasional Drinker
2.090200E-01
Non Drinker-vs-Social Drinker
3.583000E-01
Daily Drinker-vs-Weekly Drinker
4.849800E-01
Daily Drinker-vs-Occasional Drinker
3.856200E-01
Daily Drinker-vs-Social Drinker
9.580400E-01
Weekly Drinker-vs-Occasional Drinker
2.750000E-01
Weekly Drinker-vs-Social Drinker
6.353600E-01
Occasional Drinker-vs-Social Drinker
3.886400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.049400E-01
Normal-vs-Grade 2
9.543200E-01
Normal-vs-Grade 3
9.042600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.083810E-01
Grade 1-vs-Grade 3
8.176000E-02
Grade 1-vs-Grade 4
7.049400E-01
Grade 2-vs-Grade 3
2.176800E-01
Grade 2-vs-Grade 4
9.543200E-01
Grade 3-vs-Grade 4
9.042600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.078400E-01
Normal-vs-NonDiabetic
6.534800E-01
Diabetic-vs-NonDiabetic
9.218000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.952000E-01
Normal-vs-NoPancreatitis
6.937000E-01
Pancreatitis-vs-NoPancreatitis
5.102600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.165420E-01
Normal-vs-N1
7.194000E-01
N0-vs-N1
1.208220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.565200E-01
Normal-vs-TP53-NonMutant
4.276200E-02
TP53-Mutant-vs-TP53-NonMutant
8.859700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
